In Brazil, the early detection of genetic alterations in lung cancer through liquid biopsies could be a valuable tool for ...
One of the most challenging moments in cancer treatment comes when a therapy stops working. In many metastatic cancers, drugs ...
Researchers at University of California San Diego School of Medicine have led the first clinical trial in the world to show ...
The gene p53 acts as a tumor suppressor and often is called the ‘guardian of the genome.’ This gene is central to maintaining genomic stability, which prevents mutations from accumulating and leading ...
The study, published in British scientific journal Nature, suggests that the disease may begin in basal stem cells — ...
About one in five patients with cancer who undergo genetic testing are incidentally found to have mutations in their blood ...
From new imaging and targeted therapies to patient journeys, 2025 highlighted key advances and personal stories in lung ...
Researchers for the first time have identified dysfunctional immune cells in the healthy breast tissue of women with mutations in the genes BRCA1 and BRCA2, a finding that opens up the possibility of ...
A genetic fault long believed to drive the development of esophageal cancer may in fact play a protective role early in the disease, according to new research published in Nature Cancer. This ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback